1. Home
  2. SNOA vs OCTO Comparison

SNOA vs OCTO Comparison

Compare SNOA & OCTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNOA
  • OCTO
  • Stock Information
  • Founded
  • SNOA 1999
  • OCTO 1966
  • Country
  • SNOA United States
  • OCTO United States
  • Employees
  • SNOA N/A
  • OCTO N/A
  • Industry
  • SNOA Biotechnology: Pharmaceutical Preparations
  • OCTO
  • Sector
  • SNOA Health Care
  • OCTO
  • Exchange
  • SNOA Nasdaq
  • OCTO Nasdaq
  • Market Cap
  • SNOA 3.7M
  • OCTO 4.4M
  • IPO Year
  • SNOA 2007
  • OCTO N/A
  • Fundamental
  • Price
  • SNOA $2.65
  • OCTO $1.74
  • Analyst Decision
  • SNOA
  • OCTO
  • Analyst Count
  • SNOA 0
  • OCTO 0
  • Target Price
  • SNOA N/A
  • OCTO N/A
  • AVG Volume (30 Days)
  • SNOA 44.7K
  • OCTO 1.6M
  • Earning Date
  • SNOA 02-06-2025
  • OCTO 11-14-2024
  • Dividend Yield
  • SNOA N/A
  • OCTO N/A
  • EPS Growth
  • SNOA N/A
  • OCTO N/A
  • EPS
  • SNOA N/A
  • OCTO N/A
  • Revenue
  • SNOA $13,547,000.00
  • OCTO $39,835,256.00
  • Revenue This Year
  • SNOA $23.89
  • OCTO N/A
  • Revenue Next Year
  • SNOA $25.45
  • OCTO N/A
  • P/E Ratio
  • SNOA N/A
  • OCTO N/A
  • Revenue Growth
  • SNOA 11.81
  • OCTO N/A
  • 52 Week Low
  • SNOA $2.44
  • OCTO $1.26
  • 52 Week High
  • SNOA $9.40
  • OCTO $4.86
  • Technical
  • Relative Strength Index (RSI)
  • SNOA 47.13
  • OCTO 49.02
  • Support Level
  • SNOA $2.52
  • OCTO $1.56
  • Resistance Level
  • SNOA $2.80
  • OCTO $2.22
  • Average True Range (ATR)
  • SNOA 0.13
  • OCTO 0.27
  • MACD
  • SNOA 0.00
  • OCTO -0.02
  • Stochastic Oscillator
  • SNOA 39.39
  • OCTO 20.20

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

About OCTO Eightco Holdings Inc.

Eightco Holdings Inc operates in three main businesses: Forever 8 Inventory Cash Flow Solution, Web3 Business, and Packaging Business. Forever 8 focuses on purchasing inventory for e-commerce retailers and is part of its Inventory Solution Business. Web3 Business but has no intention of continuing this business at this time. The Packaging Business manufactures and sells custom packaging for a wide variety of products and helps customers generate brand awareness and promote brand image through packaging. The Company's two reportable segments were the Inventory Management Solutions segment and the Corrugated segment. Key revenue is generated from Inventory Management Solutions segment.

Share on Social Networks: